Mizuho Medy Co (TSE:4595) Additional Paid-In Capital : 円274 Mil(As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co Additional Paid-In Capital?

Mizuho Medy Co's quarterly additional paid-in capital stayed the same from Sep. 2023 (円275 Mil) to Dec. 2023 (円275 Mil) and stayed the same from Dec. 2023 (円275 Mil) to Mar. 2024 (円274 Mil).

Mizuho Medy Co's annual additional paid-in capital stayed the same from Dec. 2021 (円275 Mil) to Dec. 2022 (円275 Mil) and stayed the same from Dec. 2022 (円275 Mil) to Dec. 2023 (円275 Mil).

Mizuho Medy Co Additional Paid-In Capital Historical Data

The historical data trend for Mizuho Medy Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co Additional Paid-In Capital Chart

Mizuho Medy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

274.55

Mizuho Medy Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															274.55	274.55	274.55	274.55	274.00

Mizuho Medy Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Mizuho Medy Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Mizuho Medy Co (TSE:4595) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048

Website

http://www.mizuho-m.co.jp

Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines